$4.40
0.03[0.69%]
At close: May 10
$4.40
0[0.00%]
After Hours: 6:52PM EDT
Emergent BioSolutions
(NYSE:EBS)Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary
Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
| Open | $4.410 |
| Close | $4.350 |
| Volume / Avg. | 1.383M / 6.018M |
| Day Range | 4.210 - 4.535 |
| 52 Wk Range | 1.420 - 10.880 |
| Market Cap | $230.568M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NYSE |
| RSI | 81 |
| Short Interest | 13.77% |
| Days to Cover | 5.53 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Emergent BioSolutions (EBS) stock?
You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.
Who are Emergent BioSolutions's (EBS) competitors?
Other companies in Emergent BioSolutions’s space includes: Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS), Agenus (NASDAQ:AGEN) and Century Therapeutics (NASDAQ:IPSC).
What is the target price for Emergent BioSolutions (EBS) stock?
The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Thursday, April 11, 2024. The analyst firm set a price target for 5.00 expecting EBS to rise to within 12 months (a possible 13.64% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Emergent BioSolutions (EBS)?
The stock price for Emergent BioSolutions (NYSE: EBS) is $4.4 last updated May 10, 2024 at 6:52 PM EDT.
Does Emergent BioSolutions (EBS) pay a dividend?
There are no upcoming dividends for Emergent BioSolutions.
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Emergent BioSolutions (EBS) going to split?
There is no upcoming split for Emergent BioSolutions.
What sector and industry does Emergent BioSolutions (EBS) operate in?
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.